|
|
|
Insider
Information: |
Foletta Mark G |
Relationship: |
EVP & Chief Financial ... |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
110,512 |
|
Indirect Shares
|
59,092 |
|
|
Direct
Value |
$1,180,998 |
|
|
Indirect Value
|
$7,507,639 |
|
|
Total
Shares |
169,604 |
|
|
Total
Value |
$8,688,636 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
1
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
Percentage
Gain/Loss : |
8.1%
|
13.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amylin Pharmaceuticals Inc |
AMLN |
SVP, Chief Financial O... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
DexCom Inc |
DXCM |
Director |
2023-05-18 |
3,306 |
2023-05-18 |
59,092 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
Director |
2017-12-04 |
81,910 |
2015-08-13 |
0 |
Premium* |
|
AMN Healthcare Services Inc |
AHS |
Director |
2024-04-19 |
10,254 |
2016-04-20 |
0 |
Premium* |
|
Forte Biosciences Inc |
FBRX |
EVP & Chief Financial ... |
2019-05-28 |
15,042 |
2017-04-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
141 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DXCM |
DexCom Inc |
Director |
|
2014-11-17 |
4 |
A |
$0.00 |
$7 |
D/D |
7,322 |
7,322 |
0 |
- |
|
DXCM |
DexCom Inc |
Director |
|
2015-06-03 |
4 |
A |
$0.00 |
$5 |
D/D |
4,671 |
11,993 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2015-08-13 |
4 |
B |
$7.64 |
$76,405 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
AHS |
AMN Healthcare Services I... |
Director |
|
2016-04-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,532 |
5,532 |
0 |
- |
|
DXCM |
DexCom Inc |
Director |
|
2016-05-25 |
4 |
A |
$0.00 |
$5 |
D/D |
5,450 |
17,443 |
0 |
- |
|
DXCM |
DexCom Inc |
Director |
|
2016-09-07 |
4 |
S |
$94.63 |
$170,325 |
D/D |
(1,800) |
15,643 |
0 |
- |
|
AHS |
AMN Healthcare Services I... |
Director |
|
2016-12-15 |
4 |
S |
$37.81 |
$68,058 |
D/D |
(1,800) |
3,732 |
0 |
- |
|
AHS |
AMN Healthcare Services I... |
Director |
|
2017-04-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,793 |
7,525 |
0 |
- |
|
DXCM |
DexCom Inc |
Director |
|
2017-06-01 |
4 |
A |
$0.00 |
$5 |
D/D |
4,952 |
20,595 |
0 |
- |
|
AHS |
AMN Healthcare Services I... |
Director |
|
2017-06-13 |
4 |
S |
$36.71 |
$55,058 |
D/D |
(1,500) |
6,025 |
0 |
- |
|
AHS |
AMN Healthcare Services I... |
Director |
|
2017-11-27 |
4 |
S |
$47.03 |
$117,575 |
D/D |
(2,500) |
3,525 |
0 |
- |
|
DXCM |
DexCom Inc |
Director |
|
2017-11-27 |
4 |
S |
$54.95 |
$137,386 |
I/I |
(2,500) |
13,143 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2017-12-04 |
4 |
A |
$0.89 |
$64,000 |
D/D |
71,910 |
81,910 |
0 |
- |
|
AHS |
AMN Healthcare Services I... |
Director |
|
2018-04-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,365 |
6,890 |
0 |
- |
|
DXCM |
DexCom Inc |
Director |
|
2018-05-31 |
4 |
A |
$0.00 |
$4 |
D/D |
4,062 |
9,014 |
0 |
- |
|
DXCM |
DexCom Inc |
Director |
|
2018-06-01 |
4/A |
A |
$0.00 |
$4 |
D/D |
4,052 |
4,052 |
0 |
- |
|
DXCM |
DexCom Inc |
Director |
|
2018-08-24 |
4 |
S |
$137.50 |
$137,503 |
I/I |
(1,000) |
17,095 |
0 |
- |
|
DXCM |
DexCom Inc |
Director |
|
2019-02-15 |
4 |
AS |
$148.52 |
$148,723 |
I/I |
(1,000) |
16,095 |
0 |
- |
|
DXCM |
DexCom Inc |
Director |
|
2019-03-15 |
4 |
AS |
$146.92 |
$150,279 |
I/I |
(1,000) |
15,095 |
0 |
- |
|
DXCM |
DexCom Inc |
Director |
|
2019-04-15 |
4 |
AS |
$116.96 |
$118,977 |
I/I |
(1,000) |
14,095 |
0 |
- |
|
AHS |
AMN Healthcare Services I... |
Director |
|
2019-04-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,153 |
9,043 |
0 |
- |
|
DXCM |
DexCom Inc |
Director |
|
2019-05-15 |
4 |
AS |
$118.65 |
$121,895 |
I/I |
(1,000) |
13,095 |
0 |
- |
|
DXCM |
DexCom Inc |
Director |
|
2019-05-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,052 |
17,147 |
0 |
- |
|
DXCM |
DexCom Inc |
Director |
|
2019-05-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,052) |
0 |
0 |
- |
|
DXCM |
DexCom Inc |
Director |
|
2019-05-31 |
4 |
A |
$0.00 |
$3 |
D/D |
3,055 |
3,055 |
0 |
- |
|
141 Records found
|
|
Page 1 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|